Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
14.3M
-
Shares change
-
+470K
-
Total reported value, excl. options
-
$337M
-
Value change
-
+$5.6M
-
Number of buys
-
23
-
Number of sells
-
-30
-
Price
-
$23.75
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q3 2019
65 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q3 2019.
TransMedics Group, Inc. - Common Stock (TMDX) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.3M shares
of 33.9M outstanding shares and own 42.12% of the company stock.
Largest 10 shareholders include ABRAMS CAPITAL MANAGEMENT, L.P. (3.5M shares), FMR LLC (3.17M shares), Flagship Pioneering Inc. (2.53M shares), CREDIT SUISSE AG/ (767K shares), Zimmer Partners, LP (551K shares), RTW INVESTMENTS, LP (503K shares), Sandhill Capital Partners LLC (496K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (368K shares), VANGUARD GROUP INC (352K shares), and BlackRock Inc. (348K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.